Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the development of therapies for metabolic and endocrine disorders. The Company's clinical program, VK5211, is an orally available drug candidate, which i... Read more
MarketWatch
Yahoo
CNBC
CNBC
Access detailed stock analysis from LSEG including analyst price target estimates.